drugset / Trial / NCT02215252
A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of PF-05089771 as a monotherapy and as an add-on to pregabalin for the treatment of painful diabetic peripheral neuropathy (DPN)
Timeline
- Start
- 2014-11-10
- Primary completion
- 2015-07-15
- Completion
- 2015-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05089771 | Small molecule | 150 mg | Oral |
| Subject | Pregabalin | Small molecule | 150 mg | Oral |